Nobel-winning UK scientist launches programme to develop hepatitis C vaccine in Hong Kong

AI Summary

Nobel-winning virologist Sir Michael Houghton has launched a programme at Hong Kong Baptist University to develop a hepatitis C vaccine. The effort will draw on Hong Kong research funding, virus strains from China and partnerships with mainland drug-makers.

A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug-makers. Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C virus, said he joined Baptist University after more than four decades in North America, as the United States and...